Two Seas Capital Announces Opposition to Core Scientific's Proposed Sale to CoreWeave, Citing Undervaluation and Economic Risks
Reuters
Aug 08
Two Seas Capital Announces Opposition to <a href="https://laohu8.com/S/CORZ">Core Scientific</a>'s Proposed Sale to CoreWeave, Citing Undervaluation and Economic Risks
Core Scientific Inc. has announced a proposed merger with CoreWeave, Inc. The transaction, which has drawn criticism for its valuation and structure, is currently under scrutiny by shareholders. Core Scientific's largest active shareholder, Two Seas Capital LP, has expressed concerns that the transaction undervalues the company and exposes shareholders to economic risk. The proposed all-stock structure has been highlighted as leaving Core Scientific shareholders vulnerable to the volatility of CoreWeave's share price. Despite the criticisms, the strategic merits of a merger between the two companies have been acknowledged. Further developments and discussions are expected in the coming weeks as the parties involved continue to evaluate the proposed terms.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Core Scientific Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: NE46739) on August 07, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.